Mantle cell lymphomas lack expression of p27kip1, a cyclin-dependent kinase inhibitor

被引:97
|
作者
Quintanilla-Martinez, L
Thieblemont, C
Fend, F
Kumar, S
Pinyol, M
Campo, E
Jaffe, ES
Raffeld, M
机构
[1] NCI, Hematopathol Sect, Pathol Lab, NIH, Bethesda, MD 20892 USA
[2] Univ Barcelona, Hosp Clin Prov, Barcelona, Spain
来源
AMERICAN JOURNAL OF PATHOLOGY | 1998年 / 153卷 / 01期
基金
奥地利科学基金会;
关键词
D O I
10.1016/S0002-9440(10)65558-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
p27(Kip1) is a cyclin-dependent kinase inhibitor that regulates the decision to enter S phase or withdraw from the cell cycle. In resting cells, the level of p27(Kip1) provides an inhibitory threshold above which G1 cyclin D/E/cyclin-dependent kinases accumulate before activation; however, in cycling cells, p27(Kip1) protein is sequestered by high levels of active cyclin D/cyclin-dependent kinase 4 complexes. As a group, the cyclin-dependent kinase inhibitors have been proposed to act as tumor suppressor genes, and several members have been implicated in the pathogenesis of a variety of human cancers. We examined p27(Kip1) expression in 116 non-Hodgkin's lymphomas including 50 cases of MCL (40 typical and 10 blastic variants), 21 follicular lymphomas, 20 diffuse large B-cell lymphomas, 16 chronic lymphocytic leukemias, 8 marginal zone B-cell lymphomas, and 1 splenic marginal zone lymphoma, and correlated its expression with that of the proliferation marker Ki67 (MiB1) and with p53. p27(Kip1) gene structure was analyzed by Southern blot in the group of MCLs, In all cases of non-Hodgkin's lymphoma other than MCL, p27(Kip1) expression was inversely related to the proliferation index as measured by Ki67, In contrast, in typical MCL, p27(Kip1) expression was negative in 35 of 40 (88%) cases, irrespective of the proliferative rate (median 15%; range 2 to 90%). Paradoxically, in the blastic variant of MCL, 8 of 10 (80%) cases showed expression of p27(Kip1), despite a high proliferation rate (median 60%; range 52 to 100%). However, the staining in most of the cases was less intense than in the reactive T lymphocytes, Deletions of p27(Kip1) gene were not found in any of the 25 cases examined. p53 expression was found in 15 of 50 cases of MCL: 7 of 10 (70%) in the blastic variant and 8 of 40 (20%) in the typical MCL (70% vs. 20%, P < 0.0045), These results demonstrate that MCLs, in contrast to other non-Hodgkin's lymphomas and normal lymphoid tissue, fail to correlate p27(Kip1) expression with the proliferation rate. This peculiar uncoupling of p27(Kip1) protein expression from the proliferation rate may be related to the high levels of cyclin D1 expressed in MCL and is likely to have profound effects on cell cycle regulation and contribute to the pathogenesis of MCL.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 50 条
  • [31] The cyclin-dependent kinase inhibitor p27KIP1 is mandatory for tolerance induction in vivo.
    Li, LQ
    Berezovskaya, A
    Boussiotis, VA
    BLOOD, 2005, 106 (11) : 227A - 227A
  • [32] Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle associated proteins in mammary carcinoma
    Gillett, CE
    Smith, P
    Peters, G
    Lu, X
    Barnes, DM
    JOURNAL OF PATHOLOGY, 1999, 187 (02): : 200 - 206
  • [33] Rapamycin Regulates Endothelial Cell Migration through Regulation of the Cyclin-dependent Kinase Inhibitor p27Kip1
    Moss, Stephanie C.
    Lightell, Daniel J., Jr.
    Marx, Steven O.
    Marks, Andrew R.
    Woods, T. Cooper
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (16) : 11991 - 11997
  • [34] TGFβ prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest
    Lecanda, Jon
    Ganapathy, Vidya
    D'Aquino-Ardalan, Christine
    Evans, Brad
    Cadacio, Caprice
    Ayala, Aidee
    Gold, Leslie I.
    CELL CYCLE, 2009, 8 (05) : 742 - 756
  • [35] Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation
    Gustavo Baldassarre
    Maria Vittoria Barone
    Barbara Belletti
    Claudia Sandomenico
    Paola Bruni
    Stefania Spiezia
    Angelo Boccia
    Maria Teresa Vento
    Annunciata Romano
    Stefano Pepe
    Alfredo Fusco
    Giuseppe Viglietto
    Oncogene, 1999, 18 : 6241 - 6251
  • [36] Overexpression of a stabilized mutant form of the cyclin-dependent kinase inhibitor p27Kip1 inhibits cell growth
    Hurteau, JA
    Brutkiewicz, SA
    Wang, Q
    Allison, BM
    Goebl, MG
    Harrington, MA
    GYNECOLOGIC ONCOLOGY, 2002, 86 (01) : 19 - 23
  • [37] Cell type-specific induction of cyclin D and cyclin-dependent kinase inhibitor p27kip1 expression by estrogen in rat endometrium
    Zhuang, YH
    Sarca, D
    Weisz, A
    Altucci, L
    Cicatiello, L
    Rollerova, E
    Tuohimaa, P
    Ylikomi, T
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 78 (02): : 193 - 199
  • [38] Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation
    Baldassarre, G
    Barone, MV
    Belletti, B
    Sandomenico, C
    Bruni, P
    Spiezia, S
    Boccia, A
    Vento, MT
    Romano, A
    Pepe, S
    Fusco, A
    Viglietto, G
    ONCOGENE, 1999, 18 (46) : 6241 - 6251
  • [39] The cyclin-dependent kinase inhibitor p27Kip1 induces N-terminal proteolytic cleavage of cyclin A
    Bastians, H
    Townsley, FM
    Ruderman, JV
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15374 - 15381
  • [40] Expressions and localization of cyclin D1 and cyclin-dependent kinase inhibitor P27Kip1 in gliomas and meningiomas
    Ahmad, Farizan
    Abdullah, Jafri Malin
    Jaafar, Hasnan
    BIOMEDICAL RESEARCH-INDIA, 2009, 20 (02): : 109 - 114